Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 51

1.

The evolving drug epidemic of prescription opioid injection and its association with HCV transmission among people who inject drugs in Montréal, Canada.

Bruneau J, Arruda N, Zang G, Jutras-Aswad D, Roy É.

Addiction. 2018 Nov 6. doi: 10.1111/add.14487. [Epub ahead of print]

PMID:
30399197
2.

Thinking Beyond Legalization: The Case for Expanding Evidence-Based Options for Cannabis Use Disorder Treatment in Canada.

Jutras-Aswad D, Le Foll B, Bruneau J, Wild TC, Wood E, Fischer B.

Can J Psychiatry. 2018 Jan 1:706743718790955. doi: 10.1177/0706743718790955. [Epub ahead of print] No abstract available.

PMID:
30033757
3.

Le marché légal du cannabis suite à sa légalisation au Canada : pistes de réflexion pour un encadrement efficace.

Patenaude C, Brochu S, Fallu JS, Jutras-Aswad D, D'Arcy L.

Can J Public Health. 2018 Apr;109(2):215-218. doi: 10.17269/s41997-018-0084-z. Epub 2018 May 9.

PMID:
29981041
4.

A pilot, open-label, 8-week study evaluating desvenlafaxine for treatment of major depression in methadone-maintained individuals with opioid use disorder.

El Hage C, Ghabrash MF, Dubreucq S, Brissette S, Lespérance F, Lespérance P, Ouellet-Plamondon C, Bruneau J, Jutras-Aswad D.

Int Clin Psychopharmacol. 2018 Sep;33(5):268-273. doi: 10.1097/YIC.0000000000000223.

PMID:
29738425
5.

The OPTIMA study, buprenorphine/naloxone and methadone models of care for the treatment of prescription opioid use disorder: Study design and rationale.

Socias ME, Ahamad K, Le Foll B, Lim R, Bruneau J, Fischer B, Wild TC, Wood E, Jutras-Aswad D.

Contemp Clin Trials. 2018 Jun;69:21-27. doi: 10.1016/j.cct.2018.04.001. Epub 2018 Apr 5.

PMID:
29627621
6.

Tranquilizer misuse among active cocaine users: Predictors of initiation.

Roy É, Arruda N, Jutras-Aswad D, Berbiche D, Motta-Ochoa R, Bruneau J.

Drug Alcohol Rev. 2018 May;37(4):520-526. doi: 10.1111/dar.12666. Epub 2018 Feb 6.

PMID:
29405461
7.

Examining the Association Between Psychiatric Disorders and Cocaine Binges: Results From the COSMO Study.

Juteau LC, Roy É, Berbiche D, Arruda N, Bruneau J, Jutras-Aswad D.

J Addict Med. 2018 Mar/Apr;12(2):136-142. doi: 10.1097/ADM.0000000000000378.

PMID:
29283956
8.

Association between binge drug use and suicide attempt among people who inject drugs.

Fournier C, Ghabrash MF, Artenie A, Roy E, Zang G, Bruneau J, Jutras-Aswad D.

Subst Abus. 2017 Oct 9:1-7. doi: 10.1080/08897077.2017.1389800. [Epub ahead of print]

PMID:
28991519
9.

"I love having benzos after my coke shot": The use of psychotropic medication among cocaine users in downtown Montreal.

Motta-Ochoa R, Bertrand K, Arruda N, Jutras-Aswad D, Roy É.

Int J Drug Policy. 2017 Nov;49:15-23. doi: 10.1016/j.drugpo.2017.07.012. Epub 2017 Aug 18.

PMID:
28826127
10.

High hepatitis C incidence in relation to prescription opioid injection and poly-drug use: Assessing barriers to hepatitis C prevention.

Puzhko S, Roy É, Jutras-Aswad D, Artenie AA, Fortier E, Zang G, Bruneau J.

Int J Drug Policy. 2017 Sep;47:61-68. doi: 10.1016/j.drugpo.2017.05.027. Epub 2017 Jun 27.

PMID:
28666636
11.

Short-term injection drug use changes following hepatitis C virus (HCV) assessment and treatment among persons who inject drugs with acute HCV infection.

Artenie AA, Zang G, Daniel M, Fortier E, Jutras-Aswad D, Puzhko S, Bruneau J.

Int J Drug Policy. 2017 Sep;47:239-243. doi: 10.1016/j.drugpo.2017.05.033. Epub 2017 Jun 4.

PMID:
28587944
12.

Cannabis and cue-induced craving in cocaine-dependent individuals: A pilot study.

Giasson-Gariépy K, Potvin S, Ghabrash M, Bruneau J, Jutras-Aswad D.

Addict Behav. 2017 Oct;73:4-8. doi: 10.1016/j.addbeh.2017.03.025. Epub 2017 Mar 30.

PMID:
28431292
13.

Intentional cannabis use to reduce crack cocaine use in a Canadian setting: A longitudinal analysis.

Socías ME, Kerr T, Wood E, Dong H, Lake S, Hayashi K, DeBeck K, Jutras-Aswad D, Montaner J, Milloy MJ.

Addict Behav. 2017 Sep;72:138-143. doi: 10.1016/j.addbeh.2017.04.006. Epub 2017 Apr 4.

14.

Reversing the Atypical Valuation of Drug and Nondrug Rewards in Smokers Using Multimodal Neuroimaging.

Baker TE, Lesperance P, Tucholka A, Potvin S, Larcher K, Zhang Y, Jutras-Aswad D, Conrod P.

Biol Psychiatry. 2017 Dec 1;82(11):819-827. doi: 10.1016/j.biopsych.2017.01.015. Epub 2017 Jan 27.

PMID:
28314439
15.

Examining the link between cocaine binging and individual, social and behavioral factors among street-based cocaine users.

Roy É, Arruda N, Jutras-Aswad D, Berbiche D, Perreault M, Bertrand K, Dufour M, Bruneau J.

Addict Behav. 2017 May;68:66-72. doi: 10.1016/j.addbeh.2017.01.012. Epub 2017 Jan 6.

PMID:
28103534
16.

Prevalence and correlates of prescription opioid residue injection.

Roy É, Arruda N, Bertrand K, Dufour M, Laverdière É, Jutras-Aswad D, Perreault M, Berbiche D, Bruneau J.

Drug Alcohol Depend. 2016 Sep 1;166:69-74. doi: 10.1016/j.drugalcdep.2016.06.025. Epub 2016 Jun 29.

PMID:
27397582
17.

Examining the link between psychological distress, mental health disorders and sharing behaviors among cocaine users.

Lévesque A, Roy É, Jutras-Aswad D, Zang G, Artenie AA, Bruneau J.

Addict Behav. 2016 Nov;62:54-9. doi: 10.1016/j.addbeh.2016.06.004. Epub 2016 Jun 7.

PMID:
27318949
18.

Epidemiology of Injection Drug Use: New Trends and Prominent Issues.

Roy É, Arruda N, Bruneau J, Jutras-Aswad D.

Can J Psychiatry. 2016 Mar;61(3):136-44. doi: 10.1177/0706743716632503. Epub 2016 Feb 10. Review.

19.

Substance Use and Misuse: Emerging Epidemiological Trends, New Definitions, and Innovative Treatment Targets.

Jutras-Aswad D.

Can J Psychiatry. 2016 Mar;61(3):134-5. doi: 10.1177/0706743716632513. Epub 2016 Feb 9. No abstract available.

20.

The role of living context in prescription opioid injection and the associated risk of hepatitis C infection.

Sacks-Davis R, Daniel M, Roy É, Kestens Y, Zang G, Ramos Y, Hellard M, Jutras Aswad D, Bruneau J.

Addiction. 2016 Nov;111(11):1985-1996. doi: 10.1111/add.13470. Epub 2016 Jul 21.

PMID:
27238912

Supplemental Content

Loading ...
Support Center